Abstract
Examples disclosed herein are directed to molecular transport system (MTS) peptides and methods of using the MTS peptides. An example method comprising administering a composition to a subject, wherein the composition comprises a MTS peptide and enters the central nervous system (CNS) and wherein the MTS peptide comprises the amino acid sequence of: DAYKLQTSLDWQMWNP (SEQ ID NO:1), DGYKLQTSLDWQMWNP (SEQ ID NO:2), NQEYQHHKIKVRPSHQ (SEQ ID NO:3), FPSWTSKNQQWTNQRQ (SEQ ID NO:4), AHMSQKRLPHQVHQHQ (SEQ ID NO:5), AGNKYEYTMHQKHINK (SEQ ID NO:6), SKETYSMNAQRQHERS (SEQ ID NO:7), HRYDADRHHSFTPQYH (SEQ ID NO:8), NEEMHQAQRHHVQW (SEQ ID NO:9), or ALEPWGYKQVIKMAPN (SEQ ID NO:10).
Full Text
What is claimed is:
Examples disclosed herein are directed to molecular transport system (MTS) peptides and methods of using the MTS peptides. An example method comprising administering a composition to a subject, wherein the composition comprises a MTS peptide and enters the central nervous system (CNS) and wherein the MTS peptide comprises the amino acid sequence of: DAYKLQTSLDWQMWNP (SEQ ID NO:1), DGYKLQTSLDWQMWNP (SEQ ID NO:2), NQEYQHHKIKVRPSHQ (SEQ ID NO:3), FPSWTSKNQQWTNQRQ (SEQ ID NO:4), AHMSQKRLPHQVHQHQ (SEQ ID NO:5), AGNKYEYTMHQKHINK (SEQ ID NO:6), SKETYSMNAQRQHERS (SEQ ID NO:7), HRYDADRHHSFTPQYH (SEQ ID NO:8), NEEMHQAQRHHVQW (SEQ ID NO:9), or ALEPWGYKQVIKMAPN (SEQ ID NO:10).
Timeline
Filed
05/21/2026Published
09/10/2026Granted
Not AvailableIPC Codes(2)
C07K 7/08:having 12 to 20 amino acids
A61P 25/00:Drugs for disorders of the nervous system